149 related articles for article (PubMed ID: 8602880)
1. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
3. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.
Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C
Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
5. Time-course of butyric acid-induced differentiation in human K562 leukemic cell line: rapid increase in gamma-globin, porphobilinogen deaminase and NF-E2 mRNA levels.
Chénais B; Molle I; Trentesaux C; Jeannesson P
Leukemia; 1997 Sep; 11(9):1575-9. PubMed ID: 9305615
[TBL] [Abstract][Full Text] [Related]
6. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells.
Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A
Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation.
Buck I; Morceau F; Cristofanon S; Reuter S; Dicato M; Diederich M
Int J Oncol; 2009 Mar; 34(3):853-60. PubMed ID: 19212691
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.
Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C
J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
10. [A novel erythroid differentiation related gene EDRF1 upreguated globin gene expression in HEL cells].
Wang D; Shen B; Li Y
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1512-5. PubMed ID: 16200778
[TBL] [Abstract][Full Text] [Related]
11. The extinction of erythroid genes after tetradecanoylphorbol acetate treatment of erythroleukemic cells correlates with down-regulation of the tissue-specific factors NF-E1 and NF-E2.
Mignotte V; Navarro S; Eleouet JF; Zon LI; Romeo PH
J Biol Chem; 1990 Dec; 265(36):22090-2. PubMed ID: 2266112
[TBL] [Abstract][Full Text] [Related]
12. Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.
Miller JL; Walsh CE; Ney PA; Samulski RJ; Nienhuis AW
Blood; 1993 Sep; 82(6):1900-6. PubMed ID: 8400240
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
14. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
15. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
16. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
[TBL] [Abstract][Full Text] [Related]
17. Identification of GATA-1 and NF-E2 binding sites in the flanking regions of the human alpha-globin genes.
Gourdon G; Morlé F; Roche J; Tourneur N; Joulain V; Godet J
Acta Haematol; 1992; 87(3):136-44. PubMed ID: 1642094
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells.
Yi Z; Wang Z; Li H; Liu M
Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314
[TBL] [Abstract][Full Text] [Related]
19. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
20. Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
Gillet R; Bobichon H; Trentesaux C
Biol Cell; 2002 Sep; 94(4-5):267-73. PubMed ID: 12489695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
